Immunic Inc (IMUX)

Finanzdaten der Immunic Inc-Aktie (IMUX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	6.29%35.33	33.24	23.33	25.99	27.08
Research and Development	1.19%25.93	25.63	19.07	20.01	21.37
Provision For Loan, Lease, And Other Losses	38.41%0.21	0.15	0.34	0.05	0.06
Depreciation and Amortization	3.03%0.03	0.03	0.04	0.04	0.04
Operating Income/Loss	6.29%-35.33	-33.24	-23.33	-25.99	-27.08
Nonoperating Income/Loss	89.80%1.23	0.65	4.03	0.41	0.26
	4.64%-34.10	-32.59	-19.30	-25.58	-26.82
Attributable To Parent	4.64%-34.10	-32.59	-19.30	-25.58	-26.82
Basic Average Shares	41.07%42.51	30.14	12.88	193.90	132.18
Diluted Average Shares	41.07%42.51	30.14	12.88	193.90	132.18
Basic Earnings Per Share	25.93%-0.80	-1.08	-0.07	-0.13	-0.20
Diluted Earnings Per Share	25.93%-0.80	-1.08	-0.07	-0.13	-0.20
Common Stock Dividends	-	-	-	-	-